ZERCEPAC 60 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
ZERCEPAC 60 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
1201456002
Prescription Type
Uso Hospitalario
Authorization Date
May 28, 2021
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1201456002
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✓
Biosimilar
Yes
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
TRASTUZUMABActive
Quantity: 60 mg
Name: TRASTUZUMAB
ATC CLASSIFICATION (3)
L01F
L01FD
L01FD01